ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 40 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,176,000 | +0.1% | 5,157,000 | -0.2% | 0.12% | +6.2% |
| Q2 2021 | $5,171,000 | -93.2% | 5,165,000 | -93.1% | 0.11% | -94.3% |
| Q1 2021 | $76,559,000 | +27.7% | 74,881,000 | +36.4% | 1.97% | +17.0% |
| Q4 2020 | $59,943,000 | +35.2% | 54,881,000 | +28.9% | 1.68% | -0.4% |
| Q3 2020 | $44,351,000 | +16.5% | 42,574,000 | +23.6% | 1.69% | -1.7% |
| Q2 2020 | $38,081,000 | +7.7% | 34,448,000 | 0.0% | 1.72% | +0.3% |
| Q1 2020 | $35,346,000 | -23.0% | 34,448,000 | -14.2% | 1.72% | -38.9% |
| Q3 2019 | $45,920,000 | -3.8% | 40,132,000 | 0.0% | 2.81% | +16.7% |
| Q2 2019 | $47,726,000 | -12.4% | 40,132,000 | 0.0% | 2.41% | -25.4% |
| Q1 2019 | $54,451,000 | +32.6% | 40,132,000 | +5.2% | 3.22% | +19.1% |
| Q4 2018 | $41,064,000 | +29.3% | 38,132,000 | +27.0% | 2.71% | +42.4% |
| Q3 2018 | $31,770,000 | +26.2% | 30,025,000 | +17.3% | 1.90% | +26.3% |
| Q2 2018 | $25,171,000 | +0.6% | 25,597,000 | +2.0% | 1.51% | -4.9% |
| Q1 2018 | $25,027,000 | -5.9% | 25,097,000 | 0.0% | 1.58% | -21.6% |
| Q4 2017 | $26,583,000 | +24.7% | 25,097,000 | +25.5% | 2.02% | +21.7% |
| Q3 2017 | $21,312,000 | +25.2% | 20,000,000 | +25.0% | 1.66% | +6.4% |
| Q2 2017 | $17,021,000 | – | 16,000,000 | – | 1.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|